small lymphocytic leukemia

Lilly Wins Second Accelerated Approval for Reversible BTK Inhibitor
BioSpace
Mon, 12/4/23 - 09:41 am
Eli Lilly
FDA
Jaypirca
CLL
small lymphocytic leukemia
Btk inhibitors
Failing to confirm clinical benefit, Gilead pulls 2 accelerated approval indications for cancer drug
Endpoints
Fri, 01/21/22 - 11:07 am
Gilead Sciences
Zydelig
follicular B-cell non-Hodgkin lymphoma
small lymphocytic leukemia
AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva
Fierce Pharma
Thu, 05/16/19 - 10:53 am
AbbVie
Roche
Venclexta
CLL
small lymphocytic leukemia